Seegene Germany GmbH

Merowingerplatz 1
40225 Düsseldorf
Germany

seegene.com

About Seegene

Seegene presents a new roadmap for standardization of molecular diagnostics and brings a healthier, better future

News about Seegene

28-Mar-2011 | business & finance

Seegene and Molzym partner on automated molecular sepsis diagnostics

Seegene and Molzym announced a partnership on the automated Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate ...

Read news

23-Dec-2008 | research and development

Seegene Awarded Patent for Haplotyping Using Multiplex PCR

Haplotyping genetic screening technique promises to accelerate detection of unique personal traits for disease risk and drug response

Read news

08-Dec-2008 | research and development

Seegene Receives Approval from Health Canada for Its Respiratory Virus Multi-Pathogen Detection Tests

Seegene, Inc. announced that it has received a Medical Device License from Health Canada for its Seeplex(R) RV5 ACE (Auto Capillary Electrophoresis) ...

Read news

30-Jul-2008 | business & finance

Seegene and Shimadzu Agree to Join Multi-Pathogen Tests and Platform for Combined Analytics Solution

Seegene, Inc. and Shimadzu Corporation announced a strategic partnership to combine Seegene's Seeplex(R) multi-pathogen tests with Shimadzu's MultiNA (1) ...

Read news

22-May-2008 | business & finance

LAB901 Ltd. partners with South Korean PCR diagnostics firm, Seegene Inc.

Lab901 Ltd. announced that it has signed a distribution deal with the Korean PCR diagnostics firm Seegene Inc. Under the deal, Lab901 has appointed Seegene ...

Read news

Show more news about Seegene

Shaken bioreactors with in-situ gas analysis